Medicines and Healthcare products Regulatory Agency

An executive agency, also called MHRA

The National Institute for Biological Standards and Control (NIBSC) is part of the Medicines and Healthcare products Regulatory Agency.

296 requests
Make a request to this authority
Safety assessments and clinical trials of Hepatitis B vaccine for infants
Response by Medicines and Healthcare products Regulatory Agency to Ms Neethling on .

Awaiting classification.

Our Ref: FOI 19/322 Dear Ms Neethling, RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000 Thank you for your enquiry which we received on 17...
Case data for all reported adverse events relating to specific vaccines from 2008-2019
Response by Medicines and Healthcare products Regulatory Agency to Ms Neethling on .

Awaiting response.

Our Ref: FOI 19/303         Dear Ms Neethling,         RE:  REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000          Thank you for your enquiry at...
Did MHRA Benefit From The Ban On Co-proxamol?
Response by Medicines and Healthcare products Regulatory Agency to James Kelly on .

Successful.

Dear Mr Kelly,   Please find attached 3 of 3 email.   Kind Regards   Customer Services Communications division Medicines and Healthcare P...
Statements issued to Channel 4's Dispatches programme
Response by Medicines and Healthcare products Regulatory Agency to Bug Me Not on .

Awaiting classification.

FOI 19/280 Dear Owen Merriman, Thank you for your information request on 17 June 2019 in which you asked for: "1. Any correspondence received from...
Over-the-counter medicines containing codeine - label regulations
Response by Medicines and Healthcare products Regulatory Agency to Georgia Richards on .

Long overdue.

Dear Enquirer,   Thank you for your enquiry to the Medicines and Healthcare products Regulatory Agency. This automated response confirms that we hav...
Levothyroxine - is it orthomolecular
Response by Medicines and Healthcare products Regulatory Agency to Linda Sanday on .

Successful.

Dear Ms Sanday, Thank you for your follow-up enquiry. The level of levothyroxine in the blood when a patient may experience unwanted side effects (...
Approval of Transvaginal Mesh Medical Devices
Response by Medicines and Healthcare products Regulatory Agency to Julie Loxley on .

Awaiting classification.

Our Ref: FOI 19/300 Dear Julie Loxley, RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000 Thank you for your enquiry which we received on 2 J...
Product Verification FMD
Response by Medicines and Healthcare products Regulatory Agency to John Watts on .

Successful.

FOI 18/511   Dear Mr Watts,   Thank you for your information request, dated 11 September 2018, where you asked for information regarding whole...
Phenergan (Promethazine Hydrocloride) for insomnia
Response by Medicines and Healthcare products Regulatory Agency to Etienne Dechamps on .

Partially successful.

Dear Etienne Dechamps,   Please find attached the final response to the above referenced FOI request.   Kind regards,   FOI Licensing Team...
Cost of medicine waste or loss as a result of poor storage conditions
Response by Medicines and Healthcare products Regulatory Agency to Mr. Michael Hobby on .

Awaiting classification.

Dear Mr. Michael Hobby,         Thank you for your further email. This is information we do not hold and we suggest you could contact the Department...
How many private cannabis prescriptions have been applied for
Response by Medicines and Healthcare products Regulatory Agency to Greg de Hoedt on .

Successful.

Dear Greg de Hoedt,   Thank you for your email of 17 June where you have asked “How many licenses for a specials medicine importation has been app...
How many prescriptions have been given for Epidiolex in the UK since November 2018
Response by Medicines and Healthcare products Regulatory Agency to Greg de Hoedt on .

Awaiting classification.

Dear Greg de Hoedt, Thank you for your email to the MHRA the UK Government’s regulatory body for medicines and medical devices. The Medicines and He...
MHRA Opioid Expert Working Group
Response by Medicines and Healthcare products Regulatory Agency to Georgia Richards on .

Partially successful.

FOI Reference: 19/208 Dear Georgia Richards Thank you for your information request, dated 30 April 2019, where you asked for: 1) the list of nam...
MHRA Enforcement
Response by Medicines and Healthcare products Regulatory Agency to John Kaye on .

Refused.

Dear Mr Kaye, Thank you for your email. Please find attached response for internal review. Kind Regards Customer Services External Relations...
GcMAF Effects on Cancer and Prosecution of David Noakes
Response by Medicines and Healthcare products Regulatory Agency to George Robinson on .

Refused.

Dear Mr Robinson,   Many thanks for your information request dated 19th February 2019 regarding the product Gc Macrophage Activating Factor (GcMAF...
Opioid medicines: licensed products in England
Response by Medicines and Healthcare products Regulatory Agency to Georgia Richards on .

Successful.

FOI 19/185 Dear Georgia Richards, Re: Opioid medicines: licensed products in England Thank you for your recent enquiry to the Medicines and H...
Annual report for the JCVI
Response by Medicines and Healthcare products Regulatory Agency to Steve Hinks on .

Successful.

FOI 19/209   Dear Mr Steve Hinks,   Thank you for your email.   Please find attached the response to your FOI request.   Kind Regards...
'Yellow Card' Reports for Freestyle Libre
Response by Medicines and Healthcare products Regulatory Agency to R. Elizabeth Brady on .

Refused.

MHRA reference FOI 19/204   Dear R Brady   Thank you for your email of 28 April 2019 asking for numbers of Yellow Card reports for the Abbott...
Hpv vaccine safety and adverse reactions.
Response by Medicines and Healthcare products Regulatory Agency to Hayley on .

Partially successful.

Dear Hayley,         Thank you for your email. Please find the response to your FOI request attached.        Kind Regards, Customer and Informatio...
Genotype of confirmed laboratory measles cases
Response by Medicines and Healthcare products Regulatory Agency to Hayley on .

Information not held.

Dear Hayley, Thank you for your email. We confirm that this is for PHE to answer as measles is a reportable disease. We would not hold this type of...
GxP Inspection reports for MHRA inspections of Bristol-Myers Squibb company locations
Response by Medicines and Healthcare products Regulatory Agency to Ben Lloyd on .

Long overdue.

3^rd May 2019   Dear Requestor,   REF: FOI 19/164   As requested under the Freedom of Information Act, please find enclosed all MHRA Inspe...
Over-the-counter codeine-containing medicines: licensed products
Response by Medicines and Healthcare products Regulatory Agency to Georgia Richards on .

Successful.

Dear Georgia Richards, Re: Freedom of Information request - Over-the-counter codeine-containing medicines: licensed products our ref: ISE 19-277...
Fluoridated drinking water is used to prevent disease - why does it evade your regulation?
Response by Medicines and Healthcare products Regulatory Agency to Zac Cox on .

Awaiting classification.

Dr R Zac Cox,   Thank you for your email of 23 February and my apologies for the delay in responding.   MHRA has not ignored the basis of your...
Statistics of people suffering with liver complications which are linked to the combined oral contraceptive pill
Response by Medicines and Healthcare products Regulatory Agency to Sean Carey on .

Successful.

FOI 19/098 Dear Mr Carey, Thank you for your email. Please find attached the response to your FOI request. Kind Regards Customer Services Communi...
Break-marks on UK liothyronine tablets do not comply with PH.Eur. monograph.
Response by Medicines and Healthcare products Regulatory Agency to Thyroid Ninja on .

Partially successful.

Dear Enquirer,   Thank you for your enquiry to the Medicines and Healthcare products Regulatory Agency. This automated response confirms that we hav...

Only requests made using WhatDoTheyKnow are shown. ?